metricas
covid
Buscar en
Revista Colombiana de Reumatología
Toda la web
Inicio Revista Colombiana de Reumatología Síndrome antifosfolípido e infección por VIH
Journal Information
Vol. 17. Issue 3.
Pages 191-195 (September 2010)
Share
Share
Download PDF
More article options
Vol. 17. Issue 3.
Pages 191-195 (September 2010)
Full text access
Síndrome antifosfolípido e infección por VIH
Antiphospholipid syndrome and infection by HIV
Visits
4464
Oscar Jair Felipe-Díaz1, Mónica Gaviria2, María Cristina Trujillo Correa3, Ana María Rivas González3
1 Medicina Interna –Reumatología. Docente de Medicina Interna, Facultad de Medicina, Universidad Pontificia Bolivariana. Jefe de la Unidad de Reumatología y Enfermedades Autoinmunes, Clínica Universitaria Bolivariana. Medellín. Colombia
2 Dermatóloga. Docente, Universidad Pontificia Bolivariana. Servicio de Dermatología. Clínica Universitaria Bolivariana. Medellín. Colombia
3 Residentes de Dermatología, Facultad de Medicina, Universidad Pontificia Bolivariana, Medellín. Colombia
This item has received
Article information
Resumen

Aunque está bien documentada la alta incidencia de anticuerpos antifosfolípido (aPL) asociados a infección por virus de la inmunodeficiencia humana (VIH), hay pocos reportes de fenómenos trombóticos clínicos relacionados con la presencia de estos anticuerpos. Exponemos el caso de un paciente masculino de 47 años con diagnóstico reciente de infección por VIH que presentó síndrome antifosfolípido (SAF) manifestado por lesiones necróticas en piel de miembros inferiores y altos niveles de anticardiolipina IgG (aCL).

Palabras clave:
síndrome antifosfolípido
VIH
anticardiolipina
necrosis cutánea
Summary

Even though it is well documented the great incidence of antiphospholipid antibodies associated with HIV infection, there are few reports of clinic thrombosis related with the presence of these antibodies. We expose the case of a 47 year old male with recent diagnosis of HIV infection, presenting with antiphospholipid syndrome manifesting as necrotic skin lesions in lower limbs and high levels of IgG anticardiolipin.

Key words:
antiphospholipid syndrome
HIV
anticardiolipin
cutaneous necrosis
Full text is only aviable in PDF
Bibliografía
[1.]
T. Avcin, N. Toplak.
Antiphospholipid antibodies in response to infection.
Curr Rheumatol Rep, 9 (2007), pp. 212-218
[2.]
A.N. Leder, B. Flansbaum, G. Zandman-Goddard, R. Asherson, Y. Shoenfeld.
Antiphospholipid syndrome induced by HIV.
Lupus, 10 (2001), pp. 370-374
[3.]
A. Hassoun, Z. Al-Kadhimi, J. Cervia.
HIV infection and antiphospholipid antibody: literature review and link to the antiphospholipid syndrome.
AIDS Patient Care STDS, 18 (2004), pp. 333-340
[4.]
T. Avcin, T. Kveder, B. Rozman.
The antiphospholipid syndrome.
N Engl J Med, 347 (2002), pp. 145-146
[5.]
R. Cervera, R.A. Asherson, M.L. Acevedo, J.A. Gomez-Puerta, G. Espinosa, G. De La Red, V. Gil, M. Ramos-Casals, M. Garcia-Carrasco, M. Ingelmo, J. Font.
Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients.
Ann Rheum Dis, 63 (2004), pp. 1312-1317
[6.]
S. Argov, Y. Shattner, R. Burstein, Z.T. Handzel, Y. Shoenfeld.
Autoantibodies in male homosexuals and HIV infection.
Immunol Lett., 30 (1991), pp. 31-36
[7.]
G. Zandman-Goddard, Y. Shoenfeld.
HIV and autoimmunity.
Autoimmun Rev, 1 (2002), pp. 329-337
[8.]
R.A. Asherson, Y. Shoenfeld.
Human immunodeficiency virus infection, antiphospholipid antibodies, and the antiphospholipid syndrome.
J Rheumatol, 30 (2003), pp. 214-219
[9.]
M. Blank, I. Krause, M. Fridkin, et al.
Bacterial induction of autoantibodies to beta2-glycoprotein-I accounting for infectious etiology in antiphospholipid syndrome.
J Clin Invest, 109 (2002), pp. 797
[10.]
F. Silvestris, M.A. Frassanito, P. Cafforio, et al.
Antiphosphatidylserine antibodies in human immunodeficiencyimmunodeficiency virus-1 patients with evidence of T cell apoptosis and mediate antibody dependent cellular cytotoxicity.
Blood, 87 (1996), pp. 5185
[11.]
J. Constans, V. Guerin, A. Couchouron, et al.
Autoantibodies directed against phospholipids or human beta2-glycoprotein I in HIV seropositive patients: Relationship with endothelial activation and antimalonic dialdehyde antibodies.
Eur J Clin Invest, 28 (1998), pp. 115
[12.]
A.E. Gharavi, S.S. Pierangeli.
Origin of antiphospholipid antibodies: induction of aPL by viral peptides.
Lupus, 7 (1998), pp. S52-S54
[13.]
M. Blank, R.A. Asherson, R. Cervera, Y. Shoenfeld.
Antiphospholipid syndrome infectious origin.
J Clin Immunol, 24 (2004), pp. 12-23
[14.]
P. Von Landenberg, H.W. Lehmann, A. Knoll, et al.
Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
Arthritis Rheum, 48 (2003), pp. 1939-1947
[15.]
J. Daroca, J. Gutierrez-Cebollada, H. Yazbeck, A. Berges, J. Rubies-Prat.
Anticardiolipin antibodies and acquired immunodeficiency syndrome: prognostic marker or association with HIV infection?.
Infection, 20 (1992), pp. 140-142
[16.]
N. Abuaf, S. Laperche, B. Rajoaely, et al.
Autoantibodies to phospholipids and to the coagulation proteins in AIDS.
Thromb Haemost, 77 (1997), pp. 856
[17.]
A. Ankri, M. Bonmarchand, A. Coutellier, et al.
Antiphospholipid antibodies are an epiphenomenona in HIV infected patients.
AIDS, 13 (1999), pp. 1282
[18.]
M. Karmochkine.
Plasma hypercoagulability is correlated to plasma HIV load.
Thrombosis Haemost, 80 (1998), pp. 208
Copyright © 2010. Asociación Colombiana de Reumatología
Download PDF
Article options